Endpoint definition
↥| Name | MYELOPROF_NONCML |
|---|---|
| Long name | Myeloproliferative diseases (CML excluded) |
| Conditions required | !CML |
| Include | POLYCYTVERA, CHRONMYELOPRO, THROMBOCYTAEMIA, MYELOFIBROSIS |
| First defined in version | DF2, additional |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 779 | 422 | 357 |
| Unadjusted prevalence (%) | 0.36 | 0.34 | 0.38 |
| Mean age at first event (years) | 60.44 | 59.76 | 61.25 |
| Case fatality at 5-years (%) | 5.01 | 3.55 | 6.72 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 8.0 | 7.0 | 9.0 |
| Recurrence at 6 months (%) | 75.22 | 73.77 | 76.94 |
Survival analyses between endpoints
↥Plot
before Myeloproliferative diseases (CML excluded)
after Myeloproliferative diseases (CML excluded)
Loading survival analyses plot…
Table
Loading survival analyses table…